Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 136 Posts
1 2 3 ... 9
Leaders Reporting Tomorrow
Article By: Bespoke Investment Group Tuesday, February 5, 2019 5:35 PM EST
Among the companies set to report earnings on Wednesday are Regeneron Pharmaceuticals, Chipotle, and Spire.
In this article: REGN, CMG, SR
Read
13 Monster Stock Market Predictions For The Week Of January 28
Article By: Michael J. Kramer Sunday, January 27, 2019 12:46 PM EST
The week of January 28 will definitely not be a dull one with a monster week for earnings from tech titans and more.
In this article: NKE, ACAD, REGN, GILD, MU, NFLX, GOOGL, SQ, ROKU, BB, BABA, JD
Read
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research Wednesday, January 23, 2019 2:06 PM EST
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly Saturday, August 11, 2018 9:37 PM EST
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
Stocks For You To Swing-Trade: REGN, CMA, SCHW
Article By: Ryan Mallory Friday, August 3, 2018 6:04 AM EST
Take a look at three trading ideas to prep you for the next trading session.
In this article: CMA, SCHW, REGN
Read
Q2 Earnings Update: Bluebird Bio (BLUE) And Regeneron (REGN)
Article By: Rod Raynovich Thursday, August 2, 2018 11:09 PM EST
Regeneron Pharmaceuticals (REGN) soared 7% to $397 on earnings beat with adjusted EPS of $5.45. Bluebird Bio (BLUE) was up 0.79% to $156.60 despite losses and lagging revenue.
In this article: BLUE, REGN
Read
Biotechnology Stocks Preparing A New Bullish Trend
Article By: Taki Tsaklanos Sunday, July 8, 2018 11:26 AM EST
Biotechnology stocks look bullish, and even more bullish than ever in the last three years.
In this article: IBB, ILMN, REGN, BIIB, CELG, XBI, ARRY, FOLD, SGMO, XLRN
Read
Regeneron (REGN) Beats On Q1 Earnings
Article By: Zacks Investment Research Thursday, May 3, 2018 10:07 AM EST
Regeneron’s first-quarter 2018 earnings topped expectations. Our consensus called for EPS of $4.51 and the company reported EPS of $4.67.
In this article: REGN
Read
Regeneron Pharmaceuticals: Sequencing Its Way To +30% Upside
Article By: Matthew Hogan Thursday, May 3, 2018 6:05 AM EST
Regeneron's stock price fall over the last 10 months is not supported by the numbers. With a broadening portfolio of drugs on the market, the company is set to prove to investors that it is not a one-trick pony.
In this article: REGN Also: AET, CCE, CI, CVS, AVGO, CELG, ESRX, VRTX, YY, CC
Read
Morning Call For Monday, April 9
Article By: Jim Van Meerten Monday, April 9, 2018 10:54 AM EST
Chicago Fed President Evans said the Fed should continue gradually raising interest rates if data on consumer prices indicate inflation will soon reach its 2% target. Stocks are up as global markets rally on reduced US-China trade concerns.
In this article: DFS, GM, SYNA, KOOL, OLED, QCOM, SWKS, QRVO, BA, BEN, REGN, IAC, A, AMTD
Read
Bull Of The Day: Regeneron
Article By: Kevin Cook Wednesday, March 14, 2018 10:53 AM EST
Regeneron Pharmaceuticals shares have been on an odyssey in the past year, soaring from $360 last April up to $540 by June and then entering their own private bear market since last autumn to dip below $320 this year.
In this article: REGN Also: SNY, AMGN, BIIB, GILD
Read
3 Biotech Stocks With Rising Earnings Estimates Post Q4
Article By: Zacks Investment Research Tuesday, March 13, 2018 4:17 PM EST
The Q4 earnings season for the pharma/biotech sector was scattered with a few small biotech companies yet to report. The releases so far provide us with a clear picture of the sector’s performance.
In this article: LGND, REGN, HZNP Also: SNY, AMGN, BIIB, CELG, GILD, VRTX
Read
Regeneron, Sanofi Say Odyssey Outcomes Trial Met Primary Endpoint
Article By: The Fly Saturday, March 10, 2018 5:27 PM EST
Regeneron Pharmaceuticals and Sanofi announced that the Odyssey Outcomes trial met its primary endpoint. Praluent Injection "significantly reduced" risk of major adverse cardiovascular events in recent acute coronary syndrome patients.
In this article: SNY, REGN
Read
4 Biotech Stocks That Are Potentially Setting A Major Double Top
Article By: Taki Tsaklanos Saturday, February 24, 2018 5:20 PM EST
The following four leading biotech stocks have shown signs of fatigue and look set for mid-term bearish outlook unless a very strong buy signal would emerge in the very short term.
In this article: ILMN, REGN, BIIB, CELG
Read
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski Tuesday, February 6, 2018 3:12 PM EST
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
1 to 16 of 136 Posts
1 2 3 ... 9